210 related articles for article (PubMed ID: 11325962)
1. Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family.
Maroney AC; Finn JP; Connors TJ; Durkin JT; Angeles T; Gessner G; Xu Z; Meyer SL; Savage MJ; Greene LA; Scott RW; Vaught JL
J Biol Chem; 2001 Jul; 276(27):25302-8. PubMed ID: 11325962
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the c-Jun N-terminal kinase signaling pathway by the mixed lineage kinase inhibitor CEP-1347 (KT7515) preserves metabolism and growth of trophic factor-deprived neurons.
Harris CA; Deshmukh M; Tsui-Pierchala B; Maroney AC; Johnson EM
J Neurosci; 2002 Jan; 22(1):103-13. PubMed ID: 11756493
[TBL] [Abstract][Full Text] [Related]
3. The MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosis.
Xu Z; Maroney AC; Dobrzanski P; Kukekov NV; Greene LA
Mol Cell Biol; 2001 Jul; 21(14):4713-24. PubMed ID: 11416147
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mixed lineage kinase 3 attenuates MPP+-induced neurotoxicity in SH-SY5Y cells.
Mathiasen JR; McKenna BA; Saporito MS; Ghadge GD; Roos RP; Holskin BP; Wu ZL; Trusko SP; Connors TC; Maroney AC; Thomas BA; Thomas JC; Bozyczko-Coyne D
Brain Res; 2004 Apr; 1003(1-2):86-97. PubMed ID: 15019567
[TBL] [Abstract][Full Text] [Related]
5. CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults.
Maroney AC; Finn JP; Bozyczko-Coyne D; O'Kane TM; Neff NT; Tolkovsky AM; Park DS; Yan CY; Troy CM; Greene LA
J Neurochem; 1999 Nov; 73(5):1901-12. PubMed ID: 10537048
[TBL] [Abstract][Full Text] [Related]
6. Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway.
Maroney AC; Glicksman MA; Basma AN; Walton KM; Knight E; Murphy CA; Bartlett BA; Finn JP; Angeles T; Matsuda Y; Neff NT; Dionne CA
J Neurosci; 1998 Jan; 18(1):104-11. PubMed ID: 9412490
[TBL] [Abstract][Full Text] [Related]
7. CEP-1347/KT7515 prevents motor neuronal programmed cell death and injury-induced dedifferentiation in vivo.
Glicksman MA; Chiu AY; Dionne CA; Harty M; Kaneko M; Murakata C; Oppenheim RW; Prevette D; Sengelaub DR; Vaught JL; Neff NT
J Neurobiol; 1998 Jun; 35(4):361-70. PubMed ID: 9624618
[TBL] [Abstract][Full Text] [Related]
8. Mixed-lineage kinase inhibitors require the activation of Trk receptors to maintain long-term neuronal trophism and survival.
Wang LH; Paden AJ; Johnson EM
J Pharmacol Exp Ther; 2005 Mar; 312(3):1007-19. PubMed ID: 15525794
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of microglial inflammation by the MLK inhibitor CEP-1347.
Lund S; Porzgen P; Mortensen AL; Hasseldam H; Bozyczko-Coyne D; Morath S; Hartung T; Bianchi M; Ghezzi P; Bsibsi M; Dijkstra S; Leist M
J Neurochem; 2005 Mar; 92(6):1439-51. PubMed ID: 15748162
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mixed-lineage kinase (MLK) activity during G2-phase disrupts microtubule formation and mitotic progression in HeLa cells.
Cha H; Dangi S; Machamer CE; Shapiro P
Cell Signal; 2006 Jan; 18(1):93-104. PubMed ID: 15923109
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3beta induces neuronal cell death via direct phosphorylation of mixed lineage kinase 3.
Mishra R; Barthwal MK; Sondarva G; Rana B; Wong L; Chatterjee M; Woodgett JR; Rana A
J Biol Chem; 2007 Oct; 282(42):30393-405. PubMed ID: 17711861
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors.
Shen YH; Godlewski J; Zhu J; Sathyanarayana P; Leaner V; Birrer MJ; Rana A; Tzivion G
J Biol Chem; 2003 Jul; 278(29):26715-21. PubMed ID: 12738796
[TBL] [Abstract][Full Text] [Related]
13. Identification of JNK-dependent and -independent components of cerebellar granule neuron apoptosis.
Harris C; Maroney AC; Johnson EM
J Neurochem; 2002 Nov; 83(4):992-1001. PubMed ID: 12421372
[TBL] [Abstract][Full Text] [Related]
14. Specific modulation of astrocyte inflammation by inhibition of mixed lineage kinases with CEP-1347.
Falsig J; Pörzgen P; Lotharius J; Leist M
J Immunol; 2004 Aug; 173(4):2762-70. PubMed ID: 15294995
[TBL] [Abstract][Full Text] [Related]
15. Mixed lineage kinase 3 (MLK3)-activated p38 MAP kinase mediates transforming growth factor-beta-induced apoptosis in hepatoma cells.
Kim KY; Kim BC; Xu Z; Kim SJ
J Biol Chem; 2004 Jul; 279(28):29478-84. PubMed ID: 15069087
[TBL] [Abstract][Full Text] [Related]
16. Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential.
Bogoyevitch MA; Boehm I; Oakley A; Ketterman AJ; Barr RK
Biochim Biophys Acta; 2004 Mar; 1697(1-2):89-101. PubMed ID: 15023353
[TBL] [Abstract][Full Text] [Related]
17. A role for mixed lineage kinases in granule cell apoptosis induced by cytoskeletal disruption.
Müller GJ; Geist MA; Veng LM; Willesen MG; Johansen FF; Leist M; Vaudano E
J Neurochem; 2006 Mar; 96(5):1242-52. PubMed ID: 16478524
[TBL] [Abstract][Full Text] [Related]
18. beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation.
Troy CM; Rabacchi SA; Xu Z; Maroney AC; Connors TJ; Shelanski ML; Greene LA
J Neurochem; 2001 Apr; 77(1):157-64. PubMed ID: 11279271
[TBL] [Abstract][Full Text] [Related]
19. K252a and CEP1347 are neuroprotective compounds that inhibit mixed-lineage kinase-3 and induce activation of Akt and ERK.
Roux PP; Dorval G; Boudreau M; Angers-Loustau A; Morris SJ; Makkerh J; Barker PA
J Biol Chem; 2002 Dec; 277(51):49473-80. PubMed ID: 12388555
[TBL] [Abstract][Full Text] [Related]
20. Mixed-lineage kinases: a target for the prevention of neurodegeneration.
Wang LH; Besirli CG; Johnson EM
Annu Rev Pharmacol Toxicol; 2004; 44():451-74. PubMed ID: 14744254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
